Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Preferred Shares (2017 - 2018)

Entera Bio has reported Preferred Shares over the past 2 years, most recently at $30.9 million for Q2 2018.

  • For the quarter ending Q2 2018, Preferred Shares changed N/A year-over-year to $30.9 million, compared with a TTM value of $30.9 million through Jun 2018, changed N/A, and an annual FY2017 reading of $33.5 million, changed N/A over the prior year.
  • Preferred Shares came in at $30.9 million for Q2 2018, down from $33.5 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $33.5 million in Q4 2017 to a low of $30.9 million in Q2 2018.